AlzeCure Pharma AB (publ)

AlzeCure Pharma AB (publ)verified

ALZCUR.ST

Price:

$1.93

Market Cap:

$221.78M

AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I clinical trial for Alzheimer's disease, sleep disorders, traumatic brain injuries, and Parkinson's disease; ACD857, ACD679, and ACD680 for Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-11-28

Stock Exchange

STO

Ticker

ALZCUR.ST

The PE Ratio as of November 2025 (TTM) for AlzeCure Pharma AB (publ) (ALZCUR.ST) is -5.08

According to AlzeCure Pharma AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -5.08. This represents a change of 4.07% compared to the average of -4.88 of the last 4 quarters.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Historical PE Ratio (quarterly & annually)

How has ALZCUR.ST PE Ratio performed in the past?

The mean historical PE Ratio of AlzeCure Pharma AB (publ) over the last ten years is -5.38. The current -5.08 PE Ratio has changed 9.33% with respect to the historical average. Over the past ten years (40 quarters), ALZCUR.ST's PE Ratio was at its highest in in the June 2022 quarter at -1.23. The PE Ratio was at its lowest in in the September 2018 quarter at -10.75.

Quarterly (TTM)
Annual

Average

-5.38

Median

-3.92

Minimum

-17.41

Maximum

-2.50

AlzeCure Pharma AB (publ) (ALZCUR.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AlzeCure Pharma AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 58.16%

Maximum Annual PE Ratio = -2.50

Minimum Annual Increase = -72.07%

Minimum Annual PE Ratio = -17.41

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.50-48.81%
2023-4.8847.11%
2022-3.3221.84%
2021-2.72-39.76%
2020-4.5258.16%
2019-2.86-41.19%
2018-4.86-72.07%

AlzeCure Pharma AB (publ) (ALZCUR.ST) Average PE Ratio

How has ALZCUR.ST PE Ratio performed in the past?

The current PE Ratio of AlzeCure Pharma AB (publ) (ALZCUR.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.57

5-year avg

-3.59

10-year avg

-5.38

AlzeCure Pharma AB (publ) (ALZCUR.ST) PE Ratio vs. Peers

How is ALZCUR.ST’s PE Ratio compared to its peers?

AlzeCure Pharma AB (publ)’s PE Ratio is greater than Nanexa AB (publ) (-9.01), greater than Mentice AB (publ) (-6.22), less than Physitrack PLC (-3.58), less than Boule Diagnostics AB (publ) (-0.88), less than Enorama Pharma AB (publ) (-2.69), less than Karolinska Development AB (publ) (-2.86), less than IRLAB Therapeutics AB (publ) (-1.18), less than Klaria Pharma Holding AB (publ.) (-1.53), less than Lipum AB (publ) (-3.63), greater than AcuCort AB (-6.16),

Build a custom stock screener for AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AlzeCure Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AlzeCure Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AlzeCure Pharma AB (publ)'s PE Ratio?

How is the PE Ratio calculated for AlzeCure Pharma AB (publ) (ALZCUR.ST)?

What is the highest PE Ratio for AlzeCure Pharma AB (publ) (ALZCUR.ST)?

What is the 3-year average PE Ratio for AlzeCure Pharma AB (publ) (ALZCUR.ST)?

What is the 5-year average PE Ratio for AlzeCure Pharma AB (publ) (ALZCUR.ST)?

How does the current PE Ratio for AlzeCure Pharma AB (publ) (ALZCUR.ST) compare to its historical average?